Literature DB >> 25588709

Prevalence of Gender Nonconformity in Flanders, Belgium.

Eva Van Caenegem1, Katrien Wierckx, Els Elaut, Ann Buysse, Alexis Dewaele, Filip Van Nieuwerburgh, Griet De Cuypere, Guy T'Sjoen.   

Abstract

Gender nonconformity refers to the extent to which a person's gender identity, gender role and/or gender expression differs from the cultural norms prescribed for people of a particular sex, within a certain society and era. Most data on gender nonconformity focus on the prevalence of gender dysphoria (which also includes a distress factor) or on the number of legal sex changes. However, not every gender nonconforming individual experiences distress or applies for treatment. Population-based research on the broad spectrum of gender nonconformity is scarce and more information on the variance outside the gender binary is needed. This study aimed to examine the prevalence of gender incongruence (identifying stronger with the other sex than with the sex assigned at birth) and gender ambivalence (identifying equally with the other sex as with the sex assigned at birth) based on two population-based surveys, one of 1,832 Flemish persons and one of 2,472 sexual minority individuals in Flanders. In the general population, gender ambivalence was present in 2.2 % of male and 1.9 % of female participants, whereas gender incongruence was found in 0.7 % of men and 0.6 % of women. In sexual minority individuals, the prevalence of gender ambivalence and gender incongruence was 1.8 and 0.9 % in men and 4.1 and 2.1 % in women, respectively. With a current Flemish population of about 6 million, our results indicate a total of between 17,150 and 17,665 gender incongruent men and between 14,473 and 15,221 gender incongruent women in Flanders.

Entities:  

Mesh:

Year:  2015        PMID: 25588709     DOI: 10.1007/s10508-014-0452-6

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  24 in total

1.  A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.

Authors:  Michele Andrasik; Doug Grove; Gail Broder; Hyman Scott; Mary Allen; Shelly Karuna
Journal:  Vaccine       Date:  2019-06-05       Impact factor: 3.641

Review 2.  [Trans healthcare : Between depsychopathologization and a needs-based treatment of accompanying mental disorders].

Authors:  T O Nieder; A Güldenring; A Köhler; P Briken
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

3.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

Review 4.  Prevalence of Transgender Depends on the "Case" Definition: A Systematic Review.

Authors:  Lindsay Collin; Sari L Reisner; Vin Tangpricha; Michael Goodman
Journal:  J Sex Med       Date:  2016-03-25       Impact factor: 3.802

Review 5.  Epidemiological considerations in transgender health: A systematic review with focus on higher quality data.

Authors:  Qi Zhang; Michael Goodman; Noah Adams; Trevor Corneil; Leila Hashemi; Baudewijntje Kreukels; Joz Motmans; Rachel Snyder; Eli Coleman
Journal:  Int J Transgend Health       Date:  2020-04-15

6.  Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.

Authors:  Alison M Berner; Dean J Connolly; Imogen Pinnell; Aedan Wolton; Adriana MacNaughton; Chloe Challen; Kate Nambiar; Jacob Bayliss; James Barrett; Christina Richards
Journal:  Br J Gen Pract       Date:  2021-07-29       Impact factor: 6.302

7.  Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.

Authors:  Li Yan; Zihan Yan; Erin Wilson; Sean Arayasirikul; Jessica Lin; Hongjing Yan; Willi McFarland
Journal:  AIDS Behav       Date:  2020-09-28

8.  Androgen Suppresses In Vivo and In Vitro LH Pulse Secretion and Neural Kiss1 and Tac2 Gene Expression in Female Mice.

Authors:  Lourdes A Esparza; Tomohiro Terasaka; Mark A Lawson; Alexander S Kauffman
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

9.  Gender Expression and Its Correlates in a Nationally Representative Sample of the U.S. Adult Population: Findings from the National Survey of Sexual Health and Behavior.

Authors:  Theo G M Sandfort; Henny M W Bos; Tsung-Chieh Jane Fu; Debby Herbenick; Brian Dodge
Journal:  J Sex Res       Date:  2020-09-24

10.  Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.

Authors:  Huyen Nguyen; Benjamin Hampel; David Garcia Nuñez; Manuel Battegay; Anna Hachfeld; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Pietro Vernazza; Jacques Fellay; Hannes Rudolph; Michael Huber; Karoline Leuzinger; Matthieu Perreau; Alexandra Scherrer; Alban Nicolas Ramette; Sabine Yerly; Huldrych F Günthard; Roger D Kouyos; Katharina Kusejko
Journal:  Clin Infect Dis       Date:  2022-04-28       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.